期刊文献+

COX-2 iNOS及VEGF在胃不典型增生胃癌中的表达及其意义 被引量:9

The Significance of the Expression of COX-2, iNOS and VEGF in Gastric Atypical Hyperplasia and Gastric Cancer
在线阅读 下载PDF
导出
摘要 目的:探讨COX-2、iNOS及VEGF在胃不典型增生及胃癌中的表达、相互关系及在胃癌中的作用。方法:采用免疫组化PowervisionTM两步法对84例胃癌和54例胃不典型增生组织中COX-2、iNOS及VEGF的表达进行检测。结果:COX-2、iNOS及VEGF在胃癌中表达的阳性率分别为66.67%、77.38%、61.90%,均高于胃不典型增生组织(P<0.05)。COX-2、iNOS及VEGF表达与肿瘤的大小、淋巴结转移呈正相关,COX-2、VEGF表达与肿瘤浸润深度呈正相关,VEGF与COX-2、iNOS的表达呈正相关(P<0.05)。结论:COX-2、iNOS及VEGF与胃癌的发生、浸润转移相关,COX-2、iNOS通过增强VEGF的表达而促进肿瘤血管生成及转移。 Objective: To explore the expression and the relationship of VEGF, COX-2 and iNOS protein in gastric cancer and atypical hyperplasia. Methods: The expression of VEGF, COX-2 and iNOS were determined with Power visionTM immunohistochemical analysis in 84 gastric cancers and 54 gastric atypical hyperplasia. Results: Positive rate of COX-2 (66.67%), iNOS (77.38%), VEGF (61.90%) in gastric cancer were significantly higher than those in gastric atypical hyperplasia (P<0.05). Overexpression of COX-2,iNOS and VEGF in gastric cancer was related to lymph node metastasis and tumor size (P<0.05). There was positive correlation between the expression of VEGF, COX-2 and iNOS. And the expression of COX-2 and VEGF was positive related to the invasion of gastric cancer . Conclusions: The expression of COX-2, iNOS, VEGF may play an important role in the occurrence and progress of gastric cancer.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2005年第8期428-430,共3页 Chinese Journal of Clinical Oncology
基金 江苏省教育厅自然科学研究基金资助(编号:01KJB320011)
关键词 胃癌 胃不典型增生 血管内皮生长因子 环氧化酶2诱导型一氧化氮合酶 Gastric cancer Gastric atypical hyperplasia COX-2 iNOS VEGF
  • 相关文献

参考文献10

  • 1Lin MT, Lee RC, Yang PC, et al. Cyclooxygenase-2 Inducing Mcl-1-dependent Survival Mechanism in Human Lung Adenocarcinoma CL1.0 Cells [J]. Biol Chem, 2001, 276 (52):48997~49002.
  • 2Shono T, Tofilon PJ, Bruner JM, et al. Cyclooxygenase-2 Expression in Human Gliomas: Prognostic Significance and Molecular Correlations[J]. Cancer Res, 2001, 61(11):4375~4381.
  • 3Chang SH, Liu CH, Conway R, et al. Role of prostaglandin E2dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression[J]. PNAS, 2004, 101(2):591~596.
  • 4Takahashi Y, Kawahara F, Noguchi M, et al. Activation of matrix metalloproteinase-2 in human breast cancer cells overexpressing cyclooxygenase-1 or 2[J]. FEBS Lett, 1999, 460(1):145~148.
  • 5Phoa N, Epe B. Influence of nittic oxide on the generation and repair of oxidative DNA damage in mammalian cells[J]. Carcinogesis, 2002, 23(3):469~475.
  • 6Hussain SP, Raja K, Amstad PA, et al. Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis oxyradical overload diseases [J]. Proc Natl Acad Sci USA, 2000, 97(23):12770~12775.
  • 7Konopka TE, Barker JE, Bamford TL, et al. Nitric Oxide Synthase Ⅱ Gene Disruption: Implications for Tumor Growth and Vascular Endothelial Growth Factor Production [J]. Cancer Res,2001, 61(7):3182~3187.
  • 8Zech B, Kohl R, von Knethen A, et al. Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases[J]. Biochem, 2003, 371(Pt 3): 1055~1064.
  • 9Liu D, Jia H, Holmes DI, et al. Vascular endothelial growth factor-regulated gene expression in endothelial cells:KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurrl and Norl[J]. Arterioscler Thromb Vasc Biol, 2003, 23(11):2002~2007..
  • 10Liu D, Jia H, Holmes DI, et al. Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1[J]. Arterioscler Thromb Vasc Biol, 2003,23(11):2002~2007.

同被引文献98

引证文献9

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部